Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Bellus Health Inc (BLU.TO)

Bellus Health Inc (BLU.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bellus Health Inc 275 Armand-Frappier Boulevard Laval QC H7V 4A7 CAN

www.bellushealth.com P: 450-680-4500 F: 450-680-4501

Description:

BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, a P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, the development of drug candidates for health solutions.

Key Statistics

Overview:

Market Capitalization, $K 2,470,301
Shares Outstanding, K 126,812
Annual Sales, $ 16 K
Annual Net Income, $ -76,080 K
Last Quarter Sales, $ 3 K
Last Quarter Net Income, $ -25,060 K
60-Month Beta -0.02
% of Institutional Shareholders 10.64%

Growth:

1-Year Return 50.54%
3-Year Return 18.93%
5-Year Return 1,059.52%
5-Year Revenue Growth -34.35%

Per-Share Information:

Most Recent Earnings -0.20 on 05/12/23
Next Earnings Date 08/09/23
Earnings Per Share ttm -0.73
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 08/19/19

BLU.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -26.76%
Return-on-Assets % -25.68%
Profit Margin % -475,500.00%
Debt/Equity 0.00
Price/Sales 118,424.40
Price/Book 5.07
Book Value/Share 3.84
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar